Monsanto legal cases

10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies

Retrieved on: 
Friday, November 17, 2023
Sale, 10x Genomics, NanoString Technologies, Monsanto legal cases, UPC, Prognosis marker, Genomics, District court, Patent, RNA, Generic drug, Television, Illumina

PLEASANTON, Calif., Nov. 17, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that a jury in the U.S. District Court for the District of Delaware has reached a unanimous verdict in favor of 10x Genomics in the patent infringement suit 10x filed against the GeoMx products sold by NanoString Technologies, Inc. (Nasdaq: NSTG). In awarding over $31 million in damages, the jury found that NanoString's GeoMx Digital Spatial Profiler and associated instruments, reagents and services for RNA and protein detection willfully infringe all seven asserted patents owned by Prognosys and exclusively licensed to 10x Genomics.

Key Points: 
  • GeoMx Decision is Third Ruling Against NanoString, Showing Serial Infringement of 10x Patents
    PLEASANTON, Calif., Nov. 17, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that a jury in the U.S. District Court for the District of Delaware has reached a unanimous verdict in favor of 10x Genomics in the patent infringement suit 10x filed against the GeoMx products sold by NanoString Technologies, Inc. (Nasdaq: NSTG ).
  • "In the last six months, three separate courts have found that both NanoString's CosMx and GeoMx products infringe nine separate 10x patents," said Eric Whitaker, Chief Legal Officer at 10x Genomics.
  • "At some point, NanoString must drop the charade that it is 'confident' it does not infringe the 10x patents and the patents are invalid.
  • This ruling is the third time that NanoString has been found to infringe 10x patents in the past six months.

VoIP-Pal Provides Legal Update on the Status of Current Patent Litigation

Retrieved on: 
Monday, June 26, 2023
Patent, Intellectual property, RBR, PTAB, Attention, Judgement, Amazon, Monsanto legal cases, Hearing, Court, Verizon Communications, T-Mobile

WACO, Texas, June 26, 2023 (GLOBE NEWSWIRE) -- VoIP-Pal.com Inc. (“VoIP-Pal”, “Company”) (OTCQB: VPLM) is pleased to provide a legal update of recent developments in the current patent litigation.

Key Points: 
  • WACO, Texas, June 26, 2023 (GLOBE NEWSWIRE) -- VoIP-Pal.com Inc. (“VoIP-Pal”, “Company”) (OTCQB: VPLM) is pleased to provide a legal update of recent developments in the current patent litigation.
  • At a hearing held on June 12, 2023, in Case No.
  • Additionally, the PTAB has terminated Meta’s and Google’s involvement in IPRs filed against U.S. Patent Nos.
  • We are very happy to have him on our team as we move forward together towards achieving our monetization goals.

VPR Brands Receives Favorable Decision from The US Patent Trial and Appeal Board (PTAB)

Retrieved on: 
Thursday, July 14, 2022
Technology, Mecklermedia, Intellectual, Nicotine, Ruyan, LLC, Patent troll, Action, Monsanto legal cases, 1836 U.S. Patent Office fire, Herbal cigarette, News, U.S. Securities and Exchange Commission, Cannabis, Central District, Company, VPR, MCS, Smoke, Inhalation, Patent Trial and Appeal Board, XL, Timeline of cannabis laws in the United States, OTC, Marketing, Patent, Diaphragm, Imperial Brands, IPR, CBD, United States patent law, PTAB, NEPA, District, Tobacco Master Settlement Agreement, District court, Intellectual property, PHD, Electric Bond and Share Company v. Securities and Exchange Commission, Settlement, Generic drug, Tobacco

The PTAB determined in its decision denying institution Jupiter did not establish a reasonable likelihood that claims 13 through 18 of the Company's '622 patent are unpatentable.

Key Points: 
  • The PTAB determined in its decision denying institution Jupiter did not establish a reasonable likelihood that claims 13 through 18 of the Company's '622 patent are unpatentable.
  • The PTAB decision analyzed the prior art presented by Jupiter and rejected all prior art references.
  • The PTAB's decision denying institution clears the way for the Company's infringement litigation against Jupiter pending in the District of Arizona to proceed.
  • VPR Brands along with SRIPLAW has started to identify and notify over 50 of the leading companies using the Auto Draw Technology and VPR Brands intends to vigorously enforce its Patent.

InQuisient Announces Patent Suit Against ServiceNow

Retrieved on: 
Wednesday, July 6, 2022
Invention, District court, Monsanto legal cases, District, IP, Technology, Workflow, Complaint, Strategic planning, Data management, Metadata, Patent, ServiceNow, Solution, Database, Multimedia, 3D printing

RESTON, Va., July 6, 2022 /PRNewswire/ -- InQuisient, a recognized leader in data management and strategic enterprise planning solutions, today announced that it has filed a patent infringement suit against ServiceNow, Inc. for its unauthorized use of InQuisient's patented workflow technology.

Key Points: 
  • RESTON, Va., July 6, 2022 /PRNewswire/ -- InQuisient, a recognized leader in data management and strategic enterprise planning solutions, today announced that it has filed a patent infringement suit against ServiceNow, Inc. for its unauthorized use of InQuisient's patented workflow technology.
  • In the Complaint, which was filed in the United States District Court for the District of Delaware, InQuisient alleges infringement of some of its core patent portfolio, which dates back to 2005.
  • These pioneering patents include U.S. Patent No.
  • "InQuisient regards its intellectual property as a key asset; patents were obtained to help protect the company against the unauthorized use of its IP," said Scott Dixon Smith, Chief Executive Officer, InQuisient.

Grant & Eisenhofer Files Suit against Monsanto on Behalf of Sacramento Man Who Alleges His Cancers were Caused by Controversial Herbicide Roundup and its Key Ingredient Glyphosate

Retrieved on: 
Tuesday, June 22, 2021
Professional services, Health, Chemicals, Plastics, Environment, Legal, Manufacturing, General Health, Herbicides, Monsanto, Chemistry, Companies, Agriculture, Roundup, Glyphosate, Monsanto legal cases, Glyphosate-based herbicides

Mr. Langford purchased Roundup at a hardware store near his home supplied by Wilbur-Ellis.

Key Points: 
  • Mr. Langford purchased Roundup at a hardware store near his home supplied by Wilbur-Ellis.
  • The complaint states, Since Monsanto began selling Roundup, the company has misrepresented its safety Monsanto knew that glyphosate could pose significant risks to human health, including a risk of causing cancer.
  • After decades of distortions about its star money-making product, the company is finally considering changes to the labels on Roundup.
  • Monsanto filed suit against the state of California to stop it from warning consumers about the carcinogenic properties of glyphosate.

Fears Nachawati Trial Lawyers Praise Judge's Denial of Bayer's Flawed Proposal to Settle Cancer Claims Linked to Weed Killer

Retrieved on: 
Wednesday, May 26, 2021
Companies, Industry economics), Monsanto, Herbicides, Endocrine disruptors, Bayer, Roundup, Monsanto legal cases

Fears Nachawati represents thousands of cancer victims in lawsuits against Bayer.

Key Points: 
  • Fears Nachawati represents thousands of cancer victims in lawsuits against Bayer.
  • The herbicide was developed by Monsanto, which was acquired by Bayer in 2018.
  • Judge Chhabria pointedly criticized the settlement framework, which sought to allow Monsanto to continue selling Roundup without a warning label.
  • At the same time, it would restrict future cancer victims from seeking punitive damages in lawsuits, a provision the judge called "clearly unreasonable."

Plaintiffs Announce Proposed $2 Billion Class Settlement in Monsanto Roundup™ Injury Litigation

Retrieved on: 
Wednesday, February 3, 2021
Hispanic, Legal, Professional services, Consumer, Herbicides, Articles, Natural environment, Companies, Bayer, Monsanto, Roundup, United States Environmental Protection Agency, Settlement, Monsanto legal cases

The proposed class settlements comprehensive notice program is critical to reaching many of the class members who do not speak English as a first language.

Key Points: 
  • The proposed class settlements comprehensive notice program is critical to reaching many of the class members who do not speak English as a first language.
  • The proposed class settlement provides that Monsanto will seek permission from the Environmental Protection Agency (EPA) to add a reference link on its Roundup product labels to public scientific information about Roundup and NHL.
  • The class includes those who have been diagnosed with NHL and had exposures to Roundup prior to being diagnosed with NHL.
  • Unlike the settlement submitted to the Court in 2020 and withdrawn after the Court raised questions last July, this Settlement is a conventional mass tort class settlement.

Bayer announces agreement with plaintiffs’ counsel on class plan

Retrieved on: 
Wednesday, February 3, 2021
Health, FDA, Other Health, Fitness & Nutrition, General Health, Pharmaceutical, Veterinary, Companies, Herbicides, Industry economics), Life sciences, Roundup, Monsanto, Bayer, Vince Chhabria, Monsanto legal cases

Bayer announced today a formal agreement with plaintiffs class counsel on a class plan designed to manage and resolve future Roundup cases.

Key Points: 
  • Bayer announced today a formal agreement with plaintiffs class counsel on a class plan designed to manage and resolve future Roundup cases.
  • Plaintiffs class counsel are filing today a motion for preliminary approval of the class agreement with Judge Vince Chhabria of the U.S. District Court for the Northern District of California, who presides over the Monsanto Roundup multi-district litigation.
  • The class plan is intended to be one part of a holistic solution designed to provide further closure to the Monsanto Roundup litigation.
  • The plan also includes research and diagnostic programs that were part of the original class agreement.

The Law Offices of Frank R. Cruz Announces Investigation of Bayer Aktiengesellschaft (BAYRY) on Behalf of Investors

Retrieved on: 
Thursday, July 23, 2020
Legal, Professional services, Companies, Industries, Business, Seed companies, IG Farben, Monsanto, Bayer, Security, Bayer Corporation, Monsanto legal cases

The Law Offices of Frank R. Cruz announces an investigation on behalf of Bayer Aktiengesellschaft ("Bayer" or the "Company") (OTC: BAYRY ) investors concerning the Company and its officers possible violations of federal securities laws.

Key Points: 
  • The Law Offices of Frank R. Cruz announces an investigation on behalf of Bayer Aktiengesellschaft ("Bayer" or the "Company") (OTC: BAYRY ) investors concerning the Company and its officers possible violations of federal securities laws.
  • In June 2018, Bayer acquired Monsanto Company ("Monsanto"), a provider of agricultural chemicals and other products.
  • On this news, the Company's share price fell $3.00, or 11%, to close at $23.59 per share on August 13, 2018.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Bayer Aktiengesellschaft (BAYRY) on Behalf of Investors

Retrieved on: 
Thursday, July 23, 2020
Legal, Professional services, Companies, Industries, Business, Seed companies, IG Farben, Bayer, Monsanto, Security, Monsanto legal cases, Bayer Corporation

Law Offices of Howard G. Smith announces an investigation on behalf of Bayer Aktiengesellschaft ("Bayer" or the "Company") (OTC: BAYRY ) investors concerning the Company and its officers possible violations of federal securities laws.

Key Points: 
  • Law Offices of Howard G. Smith announces an investigation on behalf of Bayer Aktiengesellschaft ("Bayer" or the "Company") (OTC: BAYRY ) investors concerning the Company and its officers possible violations of federal securities laws.
  • In June 2018, Bayer acquired Monsanto Company ("Monsanto"), a provider of agricultural chemicals and other products.
  • On this news, the Company's share price fell $3.00, or 11%, to close at $23.59 per share on August 13, 2018.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.